NewAmsterdam Pharma Company N.V.
NAMSNASDAQNASDAQ Capital Market·USD·Closed
$31.12
−$0.32 (1.02%)
$31.12
−$0.32 (1.02%)
Not investment advice.Learn more
The signals we see for NAMS lean cautious.
We couldn't find any financial data for NAMS. Please try again later.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Mid-cap company
P/E Ratio
Div Yield
No dividend